发明申请
US20100029675A1 Pyrimidine-2, 4-diamine JAK2 Kinase inhibiting anti-inflammation use
审中-公开
嘧啶-2,4-二胺JAK2激酶抑制抗炎使用
- 专利标题: Pyrimidine-2, 4-diamine JAK2 Kinase inhibiting anti-inflammation use
- 专利标题(中): 嘧啶-2,4-二胺JAK2激酶抑制抗炎使用
-
申请号: US12460820申请日: 2009-07-23
-
公开(公告)号: US20100029675A1公开(公告)日: 2010-02-04
- 发明人: Soo-In Hwang
- 申请人: Soo-In Hwang
- 主分类号: A61K31/496
- IPC分类号: A61K31/496 ; A61P9/10 ; A61P11/06 ; A61P11/00 ; A61P3/00 ; A61P31/00 ; A61P29/00 ; A61P19/02 ; A61P31/10 ; A61P31/12 ; A61P31/04 ; A61P17/00 ; A61P27/06
摘要:
A method of treatment or prevention of Castleman's disease, atherosclerosis, coronary artery disease, peripheral edema, peripheral vascular disease, glaucoma, and wet or dry age-related macular degeneration (AMD), asthma; chronic bronchitis; chronic obstructive pulmonary disease; adult respiratory distress syndrome; infant respiratory distress syndrome; cough; chronic obstructive pulmonary disease in animals; adult respiratory distress syndrome; ulcerative colitis; Crohn's disease; hypersecretion of gastric acid; bacterial, fungal, or viral induced sepsis or septic shock; endotoxic shock; laminitis or colic in horses; spinal cord trauma; head injury; neurogenic inflammation; pain; reperfusion injury of the brain; psoriatic arthritis; rheumatoid arthritis; alkylosing spondylitis; osteoarthritis; inflammation; or cytokine-mediated chronic tissue degeneration comprises the step of administering a therapeutically effective amount, or a prophylactically effective amount, of a compound having the following structure (I):